| scholarly article | Q13442814 |
| P2093 | author name string | Alvaro Morales | |
| P2860 | cites work | Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy | Q28285210 |
| EMAS position statement: Testosterone replacement therapy in the aging male. | Q34503356 | ||
| Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth | Q34846764 | ||
| Screening and monitoring in men prescribed testosterone therapy in the U.S., 2001-2010. | Q35044878 | ||
| Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men. | Q35862931 | ||
| A survey of Canadian urologists' opinions and prescribing patterns of testosterone replacement therapy in men on active surveillance for low-risk prostate cancer | Q37301641 | ||
| Effect of testosterone administration to men with prostate cancer is unpredictable: a word of caution and suggestions for a registry | Q37868755 | ||
| Testosterone replacement therapy in the setting of prostate cancer treated with radiation | Q38042783 | ||
| Diagnosis and management of testosterone deficiency syndrome in men: clinical practice guideline | Q38616871 | ||
| Testosterone Replacement in Men with Treated and Untreated Prostate Cancer | Q38991749 | ||
| The use of radioactive phosphorus to treat bone pain in metastatic carcinoma of the prostate | Q42442928 | ||
| Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. | Q44018378 | ||
| Testosterone replacement therapy after primary treatment for prostate cancer | Q45219185 | ||
| Testosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations | Q46451575 | ||
| Response of men with advanced prostatic carcinoma to exogenous administration of testosterone. | Q53995805 | ||
| Dramatic rise in prostate-specific antigen after androgen replacement in a hypogonadal man with occult adenocarcinoma of the prostate. | Q64916759 | ||
| Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy | Q79446008 | ||
| Testosterone therapy in men with untreated prostate cancer | Q83445690 | ||
| P433 | issue | 5-6 | |
| P304 | page(s) | 185-186 | |
| P577 | publication date | 2016-05-01 | |
| P1433 | published in | Canadian Urological Association journal | Q26842808 |
| P1476 | title | Addressing the pressing issues related to testosterone administration to men with prostate cancer | |
| P478 | volume | 10 |
Search more.